Cooper Companies (NASDAQ:COO) Updates FY 2026 Earnings Guidance

Cooper Companies (NASDAQ:COO) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 4.580-4.660 for the period, compared to the consensus estimate of 4.620. The company issued revenue guidance of $4.3 billion-$4.3 billion, compared to the consensus revenue estimate of $4.3 billion.

Wall Street Analyst Weigh In

Several research firms have commented on COO. Needham & Company LLC upped their price objective on shares of Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a report on Friday, March 6th. Citigroup reiterated a “neutral” rating and issued a $69.00 price objective (down from $80.00) on shares of Cooper Companies in a research note on Thursday, May 28th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. Piper Sandler set a $86.00 price objective on shares of Cooper Companies and gave the company an “overweight” rating in a research note on Monday. Finally, Mizuho set a $85.00 price objective on shares of Cooper Companies and gave the company an “outperform” rating in a research note on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $87.00.

Cooper Companies Price Performance

Shares of Cooper Companies stock traded up $1.68 on Thursday, reaching $62.02. The stock had a trading volume of 3,915,194 shares, compared to its average volume of 2,227,562. Cooper Companies has a 1 year low of $58.89 and a 1 year high of $89.83. The company has a market cap of $12.10 billion, a P/E ratio of 30.70, a price-to-earnings-growth ratio of 1.53 and a beta of 0.87. The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22. The business’s 50 day moving average is $65.34 and its two-hundred day moving average is $74.64.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The firm had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, research analysts anticipate that Cooper Companies will post 4.62 EPS for the current year.

Trending Headlines about Cooper Companies

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Quarterly EPS came in at $1.21, above the $1.10 consensus, showing better-than-expected profitability. View Press Release
• Positive Sentiment: Revenue reached $1.08 billion, topping the $1.05 billion estimate and signaling solid demand across the business. View Press Release
• Neutral Sentiment: Management raised FY 2026 EPS guidance to 4.58-4.66, which is slightly below the Street’s 4.62 estimate at the midpoint, suggesting the outlook is good but not a big upside surprise. View Press Release
• Neutral Sentiment: The company also kept revenue guidance roughly in line with expectations, limiting the chance of a major re-rating from guidance alone. View Press Release

Institutional Investors Weigh In On Cooper Companies

A number of institutional investors and hedge funds have recently modified their holdings of the company. State Street Corp lifted its holdings in shares of Cooper Companies by 2.4% in the fourth quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock worth $720,736,000 after buying an additional 207,195 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of Cooper Companies by 332.9% in the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after buying an additional 4,756,178 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Cooper Companies by 58.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after buying an additional 2,231,568 shares in the last quarter. Sustainable Growth Advisers LP increased its position in shares of Cooper Companies by 22.1% in the third quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock worth $283,327,000 after purchasing an additional 747,476 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its position in shares of Cooper Companies by 98.8% in the second quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock worth $241,120,000 after purchasing an additional 1,683,561 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.